AiMIFYTM leverages advanced AI technology to amplify the contrast enhancement of brain MR images up to two times the level obtained with a labeled dose of gadolinium-based contrast agents (GBCAs).
Browsing: Company News
With the aim of increasing access to precision care, GE HealthCare is proud to collaborate with University Medicine Essen (UME)…
Medline recently announced it is joining forces with Microsoft to address complex supply chain challenges facing today’s healthcare professionals. Their…
Frazier Healthcare Partners, a Seattle-based, healthcare-focused investment firm, has completed the acquisition of DirectMed Imaging, a leading provider of aftermarket…
Elucid has announced that four of the seven Medicare Administrative Contractors (MACs) will extend coverage for AI-enabled quantitative coronary plaque…
Hologic Inc., a global champion of women’s health, today announced that it has signed a definitive agreement to acquire Gynesonics,…
GE HealthCare announces the commencement, and its leading industrial role, in Thera4Care, an initiative aimed at revolutionizing the use of…
Patented technology further personalizes total knee arthroplasty for surgeons and patients Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today…
Elucid has announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its PlaqueIQ imaging analysis…
GE HealthCare’s MIM Software (Nasdaq: GEHC) today announced it received 510(k) clearance from the U.S. Food and Drug Administration (FDA)…
